wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36052253-13AAD3E1-FEAD-4510-A4C5-A510A9854FC9
Q36052253-13AAD3E1-FEAD-4510-A4C5-A510A9854FC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36052253-13AAD3E1-FEAD-4510-A4C5-A510A9854FC9
Nivolumab and Olaparib.
P2860
Q36052253-13AAD3E1-FEAD-4510-A4C5-A510A9854FC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36052253-13AAD3E1-FEAD-4510-A4C5-A510A9854FC9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7cad3d574e55573b2bf339453038a42aff670e74
P2860
Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study.